Amgen
Biotechnology company developing and manufacturing therapies for serious diseases, operating in France
Highlights
- New on EvolcAdded 2026-10-28
About Amgen
Amgen France is the French subsidiary of the US biotechnology company Amgen. The site describes the company as searching for, developing and manufacturing innovative therapies for serious diseases using biological resources.
The French entity publishes news on innovation, science and corporate social responsibility, and runs the Fonds Amgen France pour la Science et l'Humain, which issues calls for projects. It also collaborates with the Hospices Civils de Lyon on clinical research and with BioLabs Hôtel-Dieu Paris on a startup award. Lyès Salah was named President of Amgen France effective 1 January 2026.
The French entity is registered in Courbevoie and was founded in 1990. The website is published in French.
Product: Biotechnology therapies for serious diseases
Public tenders won
2 tenders won since 1 Jan 2024 from 2 public buyers in France. From EU award notices (TED) that name Amgen by its registry number.
Jobs at Amgen
Leadership
- Lyès Salah · Président d'Amgen FranceSource: company website
More biotech & pharma companies
Ampleia
Venture builder creating biotech companies from research teams developing treatments for rare diseasesYoung companyNew on EvolcAnalysis Expertise
Forensic toxicology and genetic testing for courts and law enforcement agenciesYoung companyNew on EvolcAntabio
Clinical-stage biopharma developing antibiotics for multidrug-resistant hospital infections in wards and ICUsNew on Evolcanticorps-enligne.fr
Online catalogue of antibodies, ELISA kits and recombinant proteins for life science research laboratoriesNew on EvolcAntineo
Preclinical oncology research services for pharmaceutical and biotech companies and academic institutionsNew on EvolcApmonia Therapeutics
Develops peptide-based cancer therapies targeting the tumor microenvironment for patients with cancerNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- ASP.NET
- Bootstrap
- Cookiebot
- Google Tag Manager